Saral Thangam

Saral Thangam

Active Director Director DIN 01507119
DIN 01507119 First appointment Nov 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 7 historical roles
Total affiliations 9 Since Nov 2003
Shareholding value •••• Premium profile

About Saral Thangam

Data last updated:

Saral Thangam is a Director at Alvogen Pharma (India) Private Limited (since 2014) and Managing Director at Norwich Clinical Services Private Limited (since 2010). The companies operate in Pharma, Life Sciences and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Alvogen Pharma (India) Private Limited at ₹51.32 Cr (FY 2025). Earlier, Saral Thangam was a Director at Alvotech Biosciences India Private Limited (2022–2024) and Managing Director at Lotus Labs Private Limited (2006–2010) and 5 more.

DIN 01507119
Primary Designation Director
Industry Pharma
First Appointment 27 Nov 2003
Oldest Company Age 19 yrs
Largest company Alvogen Pharma (India) Private Limited · ₹51.32 Cr (FY 2025)
Combined revenue ₹103 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20142010₹51.32 Cr (FY 2025)Active
Managing Director01 Feb 20102009₹51.26 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 May 20222022₹33.54 Cr (FY 2025)Active
Lotus Labs Private Limited U73100MH1999PTC272443
Managing Director01 Nov 20061999₹54.98 Cr (FY 2025)Active
Director19 Jan 20131990₹6.2 Lakh (FY 2025)Active
Director19 Oct 20101986₹24.7 Lakh (FY 2025)Active
Director27 Nov 20032003Strike Off
Director21 Nov 20062006Amalgamated
Director07 Feb 20072007Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lotus Clinical Research Academy Private Limited
Lotus Bio Analytical Services Private Limited
Norwich Clinical Services Private Limited
Alvogen Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Saral Thangam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saral Thangam

Saral Thangam currently holds 2 directorships: Alvogen Pharma (India) Private Limited (Director, since 20 Sep 2014, revenue ₹51.32 Cr (FY 2025)); Norwich Clinical Services Private Limited (Managing Director, since 01 Feb 2010, revenue ₹51.26 Cr (FY 2025)).

Saral Thangam was first appointed on 27 Nov 2003 as Director at Shaman Scientific Information Systems Private Limited. The most recent appointment on record is 11 May 2022 at Alvotech Biosciences India Private Limited.

The 2 current companies of Saral Thangam that report revenue have a combined latest revenue of ₹103 Cr: Alvogen Pharma (India) Private Limited ₹51.32 Cr (FY 2025); Norwich Clinical Services Private Limited ₹51.26 Cr (FY 2025).

Saral Thangam held 7 earlier board appointments: Alvotech Biosciences India Private Limited (Director, 11 May 2022 to 24 May 2024); Lotus Labs Private Limited (Managing Director, 01 Nov 2006 to 19 Jan 2010); Jaya Chelve Chit Funds Private Limited (Director, 19 Jan 2013 to 29 Oct 2014); Jayachelve Financing And Leasing Private Limited (Director, 19 Oct 2010 to 29 Oct 2014); Shaman Scientific Information Systems Private Limited (Director, 27 Nov 2003 to 15 May 2017); and 2 more.

The current boards of Saral Thangam's companies include Aditya Nagaraj Bellur (Alvogen Pharma (India) Private Limited), Divya Chandu Patel (Alvogen Pharma (India) Private Limited), Fjalar Kristjansson (Alvogen Pharma (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available